Menu
Search
|

Menu

Close
X

Hypera SA HYPE3.SA (Sao Paulo Stock Exchange)

36.83 BRL
-0.17 (-0.46%)
As of Feb 17
chart
Previous Close 37.00
Open 36.70
Volume 864,900
3m Avg Volume 1,879,006
Today’s High 36.99
Today’s Low 36.26
52 Week High 37.65
52 Week Low 25.95
Shares Outstanding (mil) 632.24
Market Capitalization (mil) 21,439.19
Forward P/E 24.65
Dividend (Yield %) 1.30 ( 3.28 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.65 Mean rating from 17 analysts

KEY STATS

Revenue (mm, BRL)
FY17
2,735
FY16
3,289
FY15
1,395
EPS (BRL)
FY17
1.119
FY16
1.064
FY15
0.507
*Note: Units in Millions of Real
**Note: Units in Real

KEY RATIOS

Price to Earnings (TTM)
vs sector
24.65
32.90
Price to Sales (TTM)
vs sector
6.24
5.77
Price to Book (MRQ)
vs sector
2.73
5.41
Price to Cash Flow (TTM)
vs sector
22.60
23.42
Total Debt to Equity (MRQ)
vs sector
8.46
16.52
LT Debt to Equity (MRQ)
vs sector
4.05
12.22
Return on Investment (TTM)
vs sector
8.83
14.43
Return on Equity (TTM)
vs sector
10.30
16.13

EXECUTIVE LEADERSHIP

Joao Alves de Queiroz
Chairman of the Board, Since
Salary: --
Bonus: --
Claudio Bergamo dos Santos
Chief Executive Officer, Member of the Executive Board, Director, Since 2007
Salary: --
Bonus: --
Martim Prado Mattos
Chief Financial Officer, Chief Controllership Officer, Member of the Executive Board, Since 2014
Salary: --
Bonus: --
Vivian Karina Trujillo Angiolucci
Chief Operating Officer, Member of the Executive Board, Since 2016
Salary: --
Bonus: --
Breno Toledo Pires de Oliveira
Investor Relations Officer, Member of the Executive Board, Since 2011
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

R Nova Cidade. 404
SAO PAULO     04.547-070

Phone: +5511.36274200

Hypera SA, formerly Hypermarcas SA, is a Brazil-based company primarily engaged in the generic pharmaceuticals manufacture. The Company focuses on producing and distributing over-the-counter (OTC) drugs, branded generics, as well as prescription products. Its brand names range includes Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax and Neo Quimica, among others. In addition, the Company manufactures sweeteners under various brand names, such as Zero-Cal, Finn and Adocyl. Its production and distribution centers are located in the state of Goias, Brazil. The Company operates thorugh a number of subsidiaries, such as Brainfarma Industria Quimica e Farmaceutica SA and Cosmed Industria de Cosmeticos e Medicamentos SA.

SPONSORED STORIES